Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation

Transplantation. 2010 Apr 15;89(7):903-4. doi: 10.1097/TP.0b013e3181ccd80d.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Hemolytic-Uremic Syndrome / drug therapy*
  • Hemolytic-Uremic Syndrome / etiology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Kidney Transplantation / adverse effects*
  • Plasma Exchange
  • Recurrence
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • eculizumab